Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, NeuroOne Medical Technologies Corporation reported revenue of $9M, up 163.5% year over year. Operating margin was -46.5% and net margin -39.6%, on a free-cash-flow margin of -32.1% with capital expenditure at 0.9% of revenue. Every figure is computed directly from NMTC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $9M | -46.5% | -39.6% |
| FY2024 | $3M | -344.3% | -356.7% |
| FY2023 | $2M | -612.3% | -607.4% |
| FY2022 | $0M | -5860.2% | -5842.0% |
| FY2021 | $0M | -5735.9% | -5584.3% |
How does NMTC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.